Skip to main content
. 2024 Feb 19;11:1366769. doi: 10.3389/fmed.2024.1366769

Table 4.

Specific criteria for molecular typing of breast cancer.

Molecular subtyping criterion
Luminal A ER + and/or PR + , HER2-, Ki67 ≤ 14%
Luminal B ER + and/or PR + , HER2-, Ki67 > 14%
ER + and/or PR + , HER2 + , Ki67 at any level
TNBC ER-, PR-, HER2-
HER2 positive ER-, PR-, HER2+